Rafferty Asset Management’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.75M | Sell |
40,138
-18,844
| -32% | -$822K | 0.01% | 635 |
|
|
2025
Q1 | $1.61M | Buy |
58,982
+2,104
| +4% | +$57.6K | 0.01% | 625 |
|
|
2024
Q4 | $2.29M | Sell |
56,878
-8,573
| -13% | -$345K | 0.01% | 617 |
|
|
2024
Q3 | $3.1M | Sell |
65,451
-25,369
| -28% | -$1.2M | 0.01% | 530 |
|
|
2024
Q2 | $2.71M | Sell |
90,820
-120,041
| -57% | -$3.58M | 0.01% | 558 |
|
|
2024
Q1 | $8.48M | Buy |
210,861
+90,672
| +75% | +$3.65M | 0.03% | 332 |
|
|
2023
Q4 | $3.06M | Sell |
120,189
-29,910
| -20% | -$762K | 0.01% | 551 |
|
|
2023
Q3 | $2.09M | Sell |
150,099
-64,391
| -30% | -$895K | 0.01% | 600 |
|
|
2023
Q2 | $4.93M | Buy |
214,490
+5,401
| +3% | +$124K | 0.03% | 415 |
|
|
2023
Q1 | $6.2M | Sell |
209,089
-6,486
| -3% | -$192K | 0.04% | 337 |
|
|
2022
Q4 | $5.38M | Buy |
215,575
+35,933
| +20% | +$897K | 0.05% | 361 |
|
|
2022
Q3 | $3.91M | Buy |
179,642
+29,303
| +19% | +$638K | 0.04% | 376 |
|
|
2022
Q2 | $2.96M | Buy |
150,339
+26,211
| +21% | +$516K | 0.03% | 396 |
|
|
2022
Q1 | $5.25M | Buy |
124,128
+28,352
| +30% | +$1.2M | 0.03% | 379 |
|
|
2021
Q4 | $6.08M | Buy |
95,776
+49,027
| +105% | +$3.11M | 0.03% | 295 |
|
|
2021
Q3 | $2.75M | Sell |
46,749
-4,852
| -9% | -$285K | 0.02% | 531 |
|
|
2021
Q2 | $2.5M | Sell |
51,601
-209
| -0.4% | -$10.1K | 0.02% | 597 |
|
|
2021
Q1 | $2.01M | Buy |
+51,810
| New | +$2.01M | 0.01% | 625 |
|